共 179 条
[91]
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1999, 44 (01)
:29-38
Luo, FR
;
Wyrick, SD
;
Chaney, SG
.
[92]
High-performance liquid chromatographic separation of the biotransformation products of oxaliplatin
[J].
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,
1999, 724 (02)
:345-356
Luo, FR
;
Yen, TY
;
Wyrick, SD
;
Chaney, SG
.
[93]
Luo FR, 1999, J BIOCHEM MOL TOXIC, V13, P159, DOI 10.1002/(SICI)1099-0461(1999)13:3/4<159::AID-JBT6>3.3.CO
[94]
2-3
[95]
Luo FR, 1998, ONCOL RES, V10, P595
[96]
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1999, 44 (01)
:19-28
Luo, FR
;
Wyrick, SD
;
Chaney, SG
.
[97]
Machover D, 1996, ANN ONCOL, V7, P95
[98]
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6)
[J].
EUROPEAN JOURNAL OF CANCER,
1999, 35 (09)
:1338-1342
Maindrault-Goebel, F
;
Louvet, C
;
André, T
;
Carola, E
;
Lotz, JP
;
Molitor, JL
;
Garcia, ML
;
Gilles-Amar, V
;
Izrael, V
;
Krulik, M
;
de Gramont, A
.
[99]
MAMENTA EL, 1994, CANCER RES, V54, P3500
[100]
Mani S, 1998, ANN ONCOL, V9, P163